Clark & Stuart Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$269K Buy
+1,400
New +$228K 0.17% 47
2026
Q1
– Sell
-1,400
Closed -$229K – 53
2025
Q4
$229K Buy
+1,400
New +$219K 0.16% 46
2025
Q1
– Sell
-1,400
Closed -$202K – 44
2024
Q4
$202K Buy
+1,400
New +$201K 0.15% 43

Other funds holding RGEN

Clark & Stuart Inc's RGEN Position: Q3 2026 in Review

Clark & Stuart Inc opened a new position in Repligen (RGEN) in Q3 2026: 1,400 shares worth $269K. The stake represents 0.17% of the portfolio and ranks #47 among its holdings. This is a return to the name: Clark & Stuart Inc previously reported a position in RGEN as recently as Q4 2025.

Clark & Stuart Inc first reported a position in RGEN in Q4 2024 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Clark & Stuart Inc held 1,400 shares of Repligen worth $269K as of Q3 2026.
  • Repligen was a new Clark & Stuart Inc position in Q3 2026.
  • Repligen made up 0.17% of Clark & Stuart Inc's portfolio in Q3 2026, its #47 holding.
  • Clark & Stuart Inc first reported a position in Repligen in Q4 2024 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Clark & Stuart Inc's 13F filing for Q3 2026, filed 14 Oct 2026.